Table 7 Analysis of 28-8

From: Immunohistochemical detection of PD-L1 among diverse human neoplasms in a reference laboratory: observations based upon 62,896 cases

Tumor type

Search parameter

Number of cases

Average age, years

M:F

QNS %

Negative (<1%)

Expressed ( > 1%)

All cases

 

4191

68

2229:1978

4.7

45.5

49.8

NSCLC

[“lung” and “origin”] or [“lung” and “primary”] or [“non” and “small” and “cell”] or [“lepidic”] or [“pulmonary” and “origin”] or [“bronchogenic”] or [“NSCLC”]

530

70

49:51

4.9

41.1

54.0

Melanoma

“melanoma”

507

67

300:207

5.3

49.5

45.2

Mesothelioma

“mesothelioma”

65

66

41:24

1.5

50.8

47.7

Urothelial

“bladder” or “urothelial” or “transitional”

29

70

20:9

0

48.3

51.7

Adenocarcinoma

“adenocarcinoma”

603

69

273:330

5.5

46.9

47.6

Squamous cell carcinoma

“squamous” or “SCC” or “SCCA”

261

71

154:107

4.2

31.8

64.0

Metastatic

“metastatic”

355

66

171:184

4.2

52.4

43.4

  1. NSCLC non-small cell lung cancer